Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Predictions

buy
M/a-Com Technology Sol.

Start price
Target price
Perf. (%)
€73.50
23.08.23
€77.73
23.08.24
29.93%
19.07.24

buy
Verrica Pharmaceuticals

Start price
Target price
Perf. (%)
€3.90
23.08.23
€9.25
23.08.24
85.77%
19.07.24

buy
SI-BONE Inc

Start price
Target price
Perf. (%)
€19.30
23.08.23
€27.76
23.08.24
-22.80%
19.07.24

buy
AMC Entertainment Holdings Inc.

Start price
Target price
Perf. (%)
€1.78
23.08.23
-
23.08.24
0.90%
02.09.23

Could be worthwhile Investment >10% per year
Good culture
Few uniques
buy
Jungheinrich AG VZO

Start price
Target price
Perf. (%)
€29.74
23.08.23
-
23.08.24
4.17%
02.09.23

buy
GMS Inc

Start price
Target price
Perf. (%)
€64.50
22.08.23
-
22.08.24
26.36%
19.07.24

Sally Beauty Holdings

Start price
Target price
Perf. (%)
€8.90
22.08.23
€9.22
22.08.24
16.85%
19.07.24

buy
Fabrinet

Start price
Target price
Perf. (%)
€137.50
22.08.23
€25.82
22.08.24
58.04%
19.07.24

buy
Angie's List Inc.

Start price
Target price
Perf. (%)
€2.12
22.08.23
€4.61
22.08.24
-3.73%
19.07.24

buy
Fabrinet

Start price
Target price
Perf. (%)
€132.10
22.08.23
€151.83
22.08.24
64.50%
19.07.24

buy
flatexDEGIRO AG

Start price
Target price
Perf. (%)
€8.26
22.08.23
€9.00
22.08.24
17.87%
18.10.23

EBIT growth > 30% per year expected
Known brand
Future proof or reliable business model
Higher EBIT margin than peer group
buy
Hecla Mining Corp.

Start price
Target price
Perf. (%)
€3.85
21.08.23
€7.00
21.08.24
5.85%
03.09.23

Could be worthwhile Investment >10% per year
Revenue growth > 30% per year expected
EBIT growth > 30% per year expected
Rising EBIT margin expected
buy
Fortuna Silver Mines Inc.

Start price
Target price
Perf. (%)
€2.67
21.08.23
€5.00
21.08.24
3.71%
03.09.23

Very capable Management
Very good company culture
Leading role in innovation
Differentiated customer and product portfolio
buy
AZZ Inc.

Start price
Target price
Perf. (%)
€42.80
21.08.23
€55.03
21.08.24
82.56%
18.07.24

Singulus Technologies AG

Start price
Target price
Perf. (%)
€2.16
21.08.23
€1.00
21.08.24
4.63%
02.09.23

Little known brand
Business model of the past or high risk
Risky Investment
buy
Kezar Life Sciences

Start price
Target price
Perf. (%)
€1.15
21.08.23
-
21.08.24
21.74%
02.09.23

Could be very worthwhile Investment >20% year
buy
Aurinia Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€8.98
21.08.23
-
21.08.24
-1.45%
02.09.23

Could be very worthwhile Investment >20% year
buy
Harmony Gold Mining ADR

Start price
Target price
Perf. (%)
€3.20
21.08.23
-
21.08.24
21.88%
07.09.23

Rising EBIT margin expected
Could be very worthwhile Investment >20% year
Revenue growth > 30% per year expected
EBIT growth > 30% per year expected
buy
DRDGOLD Ltd. ADR

Start price
Target price
Perf. (%)
€8.70
21.08.23
-
21.08.24
4.02%
16.07.24

Revenue growth > 30% per year expected
EBIT growth > 30% per year expected
Could be very worthwhile Investment >20% year
Rising EBIT margin expected
buy
Blue Apron Holdings Inc.

Start price
Target price
Perf. (%)
€8.15
21.08.23
€16.30
21.09.24
-5.52%
04.09.23

Could be very worthwhile Investment >20% year
buy
Fate Therapeutics Inc.

Start price
Target price
Perf. (%)
€2.48
21.08.23
-
21.08.24
4.56%
02.09.23

Could be very worthwhile Investment >20% year
buy
MacroGenics Inc.

Start price
Target price
Perf. (%)
€4.48
21.08.23
-
21.08.24
0.00%
02.09.23

Could be very worthwhile Investment >20% year
Bellicum Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€0.36
20.08.23
-
20.08.24
-54.21%
05.03.24

Genocea Biosciences Inc.

Start price
Target price
Perf. (%)
€0.009
20.08.23
-
20.08.24
-
23.12.22

buy
Lifeway Foods Inc.

Start price
Target price
Perf. (%)
€8.40
20.08.23
-
20.08.24
33.33%
19.07.24